Abstract

Cell-based regenerative medicine therapies have been proposed for repairing the degenerated intervertebral disc (a major cause of back pain). However, for this approach to be successful, it is essential to characterise the phenotype of its native cells to guarantee that implanted cells differentiate and maintain the correct phenotype to ensure appropriate cell and tissue function. While recent studies have increased our knowledge of the human nucleus pulposus (NP) cell phenotype, their ontogeny is still unclear. The expression of notochordal markers by a subpopulation of adult NP cells suggests that, contrary to previous reports, notochord-derived cells are retained in the adult NP, possibly coexisting with a second population of cells originating from the annulus fibrosus or endplate. It is not known, however, how these two cell populations interact and their specific role(s) in disc homeostasis and disease. In particular, notochordal cells are proposed to display both anabolic and protective roles; therefore, they may be the ideal cells to repair the degenerate disc. Thus, understanding the ontogeny of the adult NP cells is paramount, as it will inform the medical and scientific communities as to the ideal phenotype to implant into the degenerate disc and the specific pathways involved in stem cell differentiation towards such a phenotype.

Highlights

  • Back pain is a major international health problem

  • While recent studies have increased our knowledge of the human nucleus pulposus (NP) cell phenotype, their ontogeny is still unclear

  • The expression of notochordal markers by a subpopulation of adult NP cells suggests that, contrary to previous reports, notochord-derived cells are retained in the adult NP, possibly coexisting with a second population of cells originating from the annulus fibrosus or endplate

Read more

Summary

Introduction

Back pain is a major international health problem. It is estimated that approximately two-thirds of the world population will experience low back pain at some point in their lives [1], with its point and one-month prevalence being, 11.9 and 23.2 %, respectively [2]. The global number of people suffering from this condition will further increase. In the USA alone, between 1997 and 2005, the estimated number of people suffering from back pain increased by 20.7 % which was accompanied by a 65 % increase (adjusted for inflation) in the overall health expenditure to treat this condition [4]. This overwhelming investment, has had no significant clinical impact as, during the same period, self-reported measurements of. Research on the intervertebral disc (IVD) has shown that disc degeneration is associated in around 40 % of cases [6] and has a probable causal relationship with back pain [7]

The intervertebral disc
The pathogenesis of disc degeneration
Therapies for disc degeneration
NP development within the IVD
NP cells in the maturing IVD
Description of the protein encoded and relevance to the IVD biology
Cellular heterogeneity in the NP
The search for the notochordal cell genetic signature
Transmembrane glycoprotein involved in neuronal guidance and angiogenesis
Findings
Pending questions and potential clinical implications
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.